Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 10;6(3):e009781.
doi: 10.1136/bmjopen-2015-009781.

What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals

Affiliations

What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals

Justin P Turner et al. BMJ Open. .

Abstract

Objectives: Polypharmacy and multimorbidity are common in long-term care facilities (LTCFs). Reducing polypharmacy may reduce adverse events and maintain quality of life. Deprescribing refers to reducing medications after consideration of therapeutic goals, benefits and risks, and medical ethics. The objective was to use nominal group technique (NGT) to generate then rank factors that general medical practitioners (GPs), nurses, pharmacists and residents or their representatives perceive are most important when deciding whether or not to deprescribe medications.

Design: Qualitative research using NGT.

Setting: Participants were invited if they worked with, or resided in LTCFs across metropolitan and regional South Australia.

Participants: 11 residents/representatives, 19 GPs, 12 nurses and 14 pharmacists participated across six separate groups.

Methods: Individual groups of GPs, nurses, pharmacists and residents/representatives were convened. Using NGT each group ranked factors perceived to be most important when deciding whether or not to deprescribe. Then, using NGT, the prioritised factors from individual groups were discussed and prioritised by a multidisciplinary metropolitan and regional group comprised of resident representatives, GPs, nurses and pharmacists.

Results: No two groups had the same priorities. GPs ranked 'evidence for deprescribing' and 'communication with family/resident' as most important factors. Nurses ranked 'GP receptivity to deprescribing' and 'nurses ability to advocate for residents' as most important. Pharmacists ranked 'clinical appropriateness of therapy' and 'identifying residents' goals of care' as most important. Residents ranked 'wellbeing of the resident' and 'continuity of nursing staff' as most important. The multidisciplinary groups ranked 'adequacy of medical and medication history' and 'identifying residents' goals of care' as most important.

Conclusions: While each group prioritised different factors, common and contrasting factors emerged. Future deprescribing interventions need to consider the similarities and differences within the range of factors prioritised by residents and health professionals.

Keywords: GERIATRIC MEDICINE; PRIMARY CARE.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for phase 1 and phase 2. GP, general medical practitioner.
Figure 2
Figure 2
Process of nominal group technique (NGT).

Similar articles

Cited by

References

    1. Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition—multimorbidity. JAMA 2012;307:2493–4. 10.1001/jama.2012.5265 - DOI - PMC - PubMed
    1. Jokanovic N, Tan EC, Dooley MJ et al. . Prevalence and factors associated with polypharmacy in long term care facilities: a systematic review. J Am Med Dir Assoc 2015;16:535.e1–12. 10.1016/j.jamda.2015.03.003 - DOI - PubMed
    1. Hilmer SN, Gnjidic D, Le Couteur DG. Thinking through the medication list—appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician 2012;41:924–8. - PubMed
    1. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5:345–51. 10.1016/j.amjopharm.2007.12.002 - DOI - PubMed
    1. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014;13:57–65. 10.1517/14740338.2013.827660 - DOI - PMC - PubMed

Publication types

LinkOut - more resources